Member Info for Soupdragon78

Egypt confirmed a case 5 days ago

4 trades in total on OTC yesterday... whoop whoop!

Head, go to this page. https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html

CDC has developed a new laboratory test kit for use in testing patient specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The test kit is called the “Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel.” It is intended for use with the Applied Biosystems 7500 Fast DX Real-Time PCR Instrument with SDS 1.4 software. This test is intended for use with upper and lower respiratory specimens collected from persons who meet CDC criteria for COVID-19 testing. CDC’s test kit is intended for use by laboratories designated by CDC as qualified, and in the United States, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. The test kits also will be shipped to qualified international laboratories, such as World Health Organization (WHO) Global Influenza Surveillance Response System (GISRS) laboratories. The test will not be available in U.S. hospitals or other primary care settings. The kits will be distributed through the International Reagent Resourceexternal icon (IRR)

Headdancer, go to the FDA website they tell you they have issued it for the new CDC test.

The article was from Monday, NCYT would have told us by now if it was their test.

Move on, the article is being used by the twitter pumping crowd.

VandV, I know that but that is not what the fool article is talking about. The simple fact is there has been a EUA issued for the CDC test and nothing else.

If FDA has been given, how come the article was published on Monday and the company hasn't said anything?

Headdancer, here's you're full quote.

"FDA highlighting that it had issued an emergency use authorization (EUA) to allow the Centers for Disease Control and Prevention to use a new test for the virus. "

This directly relates to the CDC test as below.

"On Monday, February 3, 2020, CDC submitted an Emergency Use Authorization (EUA) package to the U.S. Food and Drug Administration (FDA) in order to expedite FDA permitted use of the CDC diagnostic panel in the United States. "

"FDA issued the EUA on February 4, 2020."

No it hasn't headdancer, the motley fool article is from Monday and contains nothing thats not already known.

Just people pumping on twitter, link is to an old article referring to the CDC test.

NCYT is one of the 50 EUA applications still pending.

£5.80 recommendation was by an enthusiasts blog, it even says this on the site it was posted. Not a broker note.

It has the same weight as anyone on here posting.

Stocks, there have been 10 trades in a week on the Nasdaq OTC. That tells you its not worth looking at.
It'll track what happens here, not the other way around.

Was trading on OTC last week. Hardly anything so not worth paying attention to.

Doesn't have to be FDA approved as its for research only.

Oaber, thats a different strain. MERS is Middle East specific and has been around for years.

Rolling over an existing position surely.

The important thing was always confirmation of discussions, the figures will be what they'll be.

Now, either Level 2 is knackered or we've go the bizarre situation of 6 v 6 with 6 sat on 7p and 6 sat on 8p?!!

To quote Dan.

"There were some wild amounts thrown around... I think its very rare for any drug company to sign a royalty deal for something like £200m a year, that just doesn't happen."

The video is on the NFX website.

Although Dan did say the numbers in the rumour were over the top.

Could also go the other way.

Same, can easily get a price to sell 400k+.

Canary, the active date is just the status today, look on any other patent.